218 related articles for article (PubMed ID: 35114912)
1. Notoginsenoside R1, An Active Compound from
Gong X; Shan L; Cao S; Li K; Wu Y; Zhang Q
Am J Chin Med; 2022; 50(2):511-523. PubMed ID: 35114912
[TBL] [Abstract][Full Text] [Related]
2. Effects of the Combination of the Main Active Components of Astragalus and Panax notoginseng on Inflammation and Apoptosis of Nerve Cell after Cerebral Ischemia-Reperfusion.
Huang XP; Ding H; Lu JD; Tang YH; Deng BX; Deng CQ
Am J Chin Med; 2015; 43(7):1419-38. PubMed ID: 26477799
[TBL] [Abstract][Full Text] [Related]
3. Nrf2 pathway activation contributes to anti-fibrosis effects of ginsenoside Rg1 in a rat model of alcohol- and CCl4-induced hepatic fibrosis.
Li JP; Gao Y; Chu SF; Zhang Z; Xia CY; Mou Z; Song XY; He WB; Guo XF; Chen NH
Acta Pharmacol Sin; 2014 Aug; 35(8):1031-44. PubMed ID: 24976156
[TBL] [Abstract][Full Text] [Related]
4.
Luo H; Vong CT; Tan D; Zhang J; Yu H; Yang L; Zhang C; Luo C; Zhong Z; Wang Y
Am J Chin Med; 2021; 49(4):925-939. PubMed ID: 33829964
[No Abstract] [Full Text] [Related]
5. Gypenosides Ameliorate Carbon Tetrachloride-Induced Liver Fibrosis by Inhibiting the Differentiation of Hepatic Progenitor Cells into Myofibroblasts.
Chen J; Li X; Hu Y; Liu W; Zhou Q; Zhang H; Mu Y; Liu P
Am J Chin Med; 2017; 45(5):1061-1074. PubMed ID: 28659031
[TBL] [Abstract][Full Text] [Related]
6. Hepatoprotective effect of total flavonoids of Mallotus apelta (Lour.) Muell.Arg. leaf against carbon tetrachloride-induced liver fibrosis in rats via modulation of TGF-β1/Smad and NF-κB signaling pathways.
Zhang B; Lai L; Tan Y; Liang Q; Bai F; Mai W; Huang Q; Ye Y
J Ethnopharmacol; 2020 May; 254():112714. PubMed ID: 32105750
[TBL] [Abstract][Full Text] [Related]
7. Notoginsenoside R1 targets PPAR-γ to inhibit hepatic stellate cell activation and ameliorates liver fibrosis.
Guo C; Lai L; Ma B; Huang Q; Wang Z
Exp Cell Res; 2024 Apr; 437(1):113992. PubMed ID: 38492634
[TBL] [Abstract][Full Text] [Related]
8. Paeoniflorin Coordinates Macrophage Polarization and Mitigates Liver Inflammation and Fibrogenesis by Targeting the NF-[Formula: see text]B/HIF-1α Pathway in CCl
Liu Y; He CY; Yang XM; Chen WC; Zhang MJ; Zhong XD; Chen WG; Zhong BL; He SQ; Sun HT
Am J Chin Med; 2023; 51(5):1249-1267. PubMed ID: 37317554
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of MAPK and NF-κB signaling pathways alleviate carbon tetrachloride (CCl4)-induced liver fibrosis in Toll-like receptor 5 (TLR5) deficiency mice.
Shu M; Huang DD; Hung ZA; Hu XR; Zhang S
Biochem Biophys Res Commun; 2016 Feb; 471(1):233-9. PubMed ID: 26845355
[TBL] [Abstract][Full Text] [Related]
10. RNA-seq combined network pharmacology reveals that Fu-Gan-Wan (FGW) inhibits liver fibrosis via NF-κB/CCL2/CCR2 and lipid peroxidation via Nrf2/HMOX1 signaling pathway.
Shi H; Duan X; Dong J; Tao Y; Lei Y
J Ethnopharmacol; 2024 May; 326():117963. PubMed ID: 38387680
[TBL] [Abstract][Full Text] [Related]
11. Glabridin inhibits liver fibrosis and hepatic stellate cells activation through suppression of inflammation and oxidative stress by activating PPARγ in carbon tetrachloride-treated mice.
Zhang L; Zhang H; Gu J; Xu W; Yuan N; Sun J; Li H
Int Immunopharmacol; 2022 Dec; 113(Pt B):109433. PubMed ID: 36371863
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of quercetin on the progression of liver fibrosis through the regulation of NF-кB/IкBα, p38 MAPK, and Bcl-2/Bax signaling.
Wang R; Zhang H; Wang Y; Song F; Yuan Y
Int Immunopharmacol; 2017 Jun; 47():126-133. PubMed ID: 28391159
[TBL] [Abstract][Full Text] [Related]
13. Knockout of the Cannabinoid Receptor 2 Gene Promotes Inflammation and Hepatic Stellate Cell Activation by Promoting A20/Nuclear Factor-κB (NF-κB) Expression in Mice with Carbon Tetrachloride-Induced Liver Fibrosis.
Long C; Xie N; Shu Y; Wu Y; He P; Zhou Y; Xiang Y; Gu J; Yang L; Wang Y
Med Sci Monit; 2021 Aug; 27():e931236. PubMed ID: 34413280
[TBL] [Abstract][Full Text] [Related]
14. Salvianolic acid A suppresses CCl
Li S; Wang R; Song F; Chen P; Gu Y; Chen C; Yuan Y
Drug Chem Toxicol; 2023 Mar; 46(2):304-313. PubMed ID: 35057680
[TBL] [Abstract][Full Text] [Related]
15. Oligo-peptide I-C-F-6 inhibits hepatic stellate cell activation and ameliorates CCl
Sun H; Chen G; Wen B; Sun J; An H; Pang J; Xu W; Yang X; He S
J Pharmacol Sci; 2018 Mar; 136(3):133-141. PubMed ID: 29501581
[TBL] [Abstract][Full Text] [Related]
16. Pien-Tze-Huang ameliorates hepatic fibrosis via suppressing NF-κB pathway and promoting HSC apoptosis.
Zheng H; Wang X; Zhang Y; Chen L; Hua L; Xu W
J Ethnopharmacol; 2019 Nov; 244():111856. PubMed ID: 30959141
[TBL] [Abstract][Full Text] [Related]
17. Docosahexaenoic acid attenuates carbon tetrachloride-induced hepatic fibrosis in rats.
He J; Bai K; Hong B; Zhang F; Zheng S
Int Immunopharmacol; 2017 Dec; 53():56-62. PubMed ID: 29035816
[TBL] [Abstract][Full Text] [Related]
18. Effects of interleukin-10 on activation and apoptosis of hepatic stellate cells in fibrotic rat liver.
Zhang LJ; Zheng WD; Shi MN; Wang XZ
World J Gastroenterol; 2006 Mar; 12(12):1918-23. PubMed ID: 16609999
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the possible roles of SB-269970 versus ketanserin on carbon tetrachloride-induced liver fibrosis in rats: Oxidative stress/TGF-β
Atallah MAA; Elaidy SM; Tawfik MK
Pharmacol Rep; 2018 Jun; 70(3):509-518. PubMed ID: 29660654
[TBL] [Abstract][Full Text] [Related]
20. Cell-specific PPARγ deficiency establishes anti-inflammatory and anti-fibrogenic properties for this nuclear receptor in non-parenchymal liver cells.
Morán-Salvador E; Titos E; Rius B; González-Périz A; García-Alonso V; López-Vicario C; Miquel R; Barak Y; Arroyo V; Clària J
J Hepatol; 2013 Nov; 59(5):1045-53. PubMed ID: 23831119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
